Company intelligence / Profile preview

Marajoara

San Diego, California, United Statesen.citaliarestauro.com ↗

Ownership: Private
Development stage: Other

Overview

Maravai LifeSciences is a leading global provider of life science reagents and services that enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. Its brands are recognized for expertise in nucleic acid synthesis—including mRNA manufacturing—and biologics safety testing. The company’s offerings are widely used by biopharmaceutical companies to accelerate discovery through clinical manufacturing.

Modalities: mRNA-based drugsSmall molecule (via nucleic acid synthesis)Gene therapy (enabling technologies)Vaccine (enabling technologies)
Industry: Contract Manufacturing Organization

Partnerships

TriLink BioTechnologies & Alphazyme collaborationpartnerships with major biopharma companies as customers

Beyond the preview

Go deeper on Marajoara.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marajoara.

Explore the full profile